CLINICAL SUPPLY MANAGEMENT ARTICLES
Why Clinical Supply Problems Rarely Start In Clinical Supply
Clinical supply failures often start long before a stockout, when CMC, quality, regulatory, and clinical decisions create risks that supply teams inherit too late.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Historically managed through late-stage adjustments, operational adaptability has become a strategic imperative to prevent programs from stalling under real-world pressures.
-
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Sponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.